Neuralgic amyotrophy following botulinum toxin injection

Parkinsonism and Related Disorders

Volumn 16, Issue 4, 2010, Pages 301-302

  Alcalay, Roy N ^a,b,c   Simões, Rita M ^a,b,c   Feigin, Andrew ^a,b,c   Frucht, Steven ^a,b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Hospital Professor Doutor Fernando Fonseca   (Portugal)

^c Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; OXYCODONE;

AGED; CASE REPORT; CERVICAL DYSTONIA; CUBITAL TUNNEL SYNDROME; DISEASE SEVERITY; EDEMA; ELECTROMYOGRAM; FEMALE; HUMAN; LETTER; MUSCLE ATROPHY; NEURALGIC MUSCLE ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRIORITY JOURNAL; STERNOCLEIDOMASTOID MUSCLE; WEAKNESS;

AGED; BOTULINUM TOXIN TYPE A; BRACHIAL PLEXUS NEURITIS; CERVICAL VERTEBRAE; DYSTONIA; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MAGNETIC RESONANCE IMAGING; NECK; NEUROMUSCULAR AGENTS;

EID: 77952886568     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.09.007     Document Type: Letter

References (17)

1. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 2004, 75:951-957.
2. Cote T.R., Mohan A.K., Polder J.A., Walton M.K., Braun M.M. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005, 53:407-415.
3. Girlanda P., Vita G., Nicolosi C., Milone S., Messina C. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 1992, 55:844-845.
4. Chertow D.S., Tan E.T., Maslanka S.E., Schulte J., Bresnitz E.A., Weisman R.S., et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA 2006, 296:2476-2479.
5. LeWitt P.A., Trosch R.M. Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection. Mov Disord 1997, 12:1064-1067.
6. Scalf R.E., Wenger D.E., Frick M.A., Mandrekar J.N., Adkins M.C. MRI findings of 26 patients with Parsonage-Turner syndrome. AJR Am J Roentgenol 2007, 189:W39-W44.
7. van Alfen N., van Engelen B.G. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006, 129:438-450.
8. Sampaio C., Castro-Caldas A., Sales-Luis M.I., Alves M., Pinto L., Apolinario P. Brachial plexopathy after botulinum toxin administration for cervical dystonia. J Neurol Neurosurg Psychiatry 1993, 56:220.
9. Sheean G.L., Murray N.M., Marsden C.D. Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp. Lancet 1995, 346:154-156.
10. Tarsy D. Brachial plexus neuropathy after botulinum toxin injection. Neurology 1997, 49:1176-1177.
11. Glanzman R.L., Gelb D.J., Drury I., Bromberg M.B., Truong D.D. Brachial plexopathy after botulinum toxin injections. Neurology 1990, 40:1143.
12. Beghi E., Kurland L.T., Mulder D.W., Nicolosi A. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Ann Neurol 1985, 18:320-323.
13. Shioyama M., Akamatsu M., Mitsui Y., Sada M., Hirakawa M., Kusunoki S. A case of neuralgic amyotrophy with antiganglioside antibody. Rinsho Shinkeigaku 2006, 46:722-724.
14. Sierra A., Prat J., Bas J., Romeu A., Montero J., Matos J.A., et al. Blood lymphocytes are sensitized to branchial plexus nerves in patients with neuralgic amyotrophy. Acta Neurol Scand 1991, 83:183-186.
15. Burguera J.A., Villaroya T., Lopez-Alemany M. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol 2000, 23:226-228.
16. Onoue H., Matsunobu A., Nagaishi A., Yukitake M., Kuroda Y. A case report of acute polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia. Rinsho Shinkeigaku 2004, 44:20-24.
17. Haug B.A., Dressler D., Prange H.W. Polyradiculoneuritis following botulinum toxin therapy. J Neurol 1990, 237:62-63.